AIM IMMUNOTECH INC. Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage
AIM IMMUNOTECH INC. (AIM) reported Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage of 6.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs
us-gaap:DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage · last filed 2026-08-07
- AIM IMMUNOTECH INC. deferred compensation arrangement with individual, cash awards granted, percentage for the quarter ending 2026-03-31 was 6.00%.
- AIM IMMUNOTECH INC. deferred compensation arrangement with individual, cash awards granted, percentage for fiscal 2025 was 6.00%, a 0.00% change from fiscal 2024.
- AIM IMMUNOTECH INC. deferred compensation arrangement with individual, cash awards granted, percentage for fiscal 2024 was 6.00%, a 0.00% change from fiscal 2023.
- AIM IMMUNOTECH INC. deferred compensation arrangement with individual, cash awards granted, percentage for fiscal 2023 was 6.00%, a 0.00% change from fiscal 2022.
- AIM IMMUNOTECH INC. deferred compensation arrangement with individual, cash awards granted, percentage for fiscal 2022 was 6.00%, a 0.00% change from fiscal 2021.
| Period end | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 3 month | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 6 month | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 9 month | Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage 12 month |
|---|---|---|---|---|
| 2026-06-30 | 6.00% 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 6.00% 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 6.00% 10-K · filed 2026-03-27 | |||
| 2025-09-30 | 6.00% 10-Q · filed 2025-11-17 | |||
| 2024-12-31 | 6.00% 10-K · filed 2025-03-27 | |||
| 2023-12-31 | 6.00% 10-K · filed 2024-04-01 | |||
| 2022-12-31 | 6.00% 10-K · filed 2023-03-31 | |||
| 2021-12-31 | 6.00% 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |